CONSORTIUM

Prof. Timothy Noël

Timothy Noël received in 2004 his MSc degree (Industrial Chemical Engineering) in Ghent. He then moved to Ghent University to obtain a PhD in synthetic organic chemistry (2005-2009). Next, he crossed the ocean to work at the Massachusetts Institute of Technology (MIT) as a Fulbright Postdoctoral Fellow with Professor Stephen L. Buchwald. Returning to Europe, he became assistant professor in 2012 and associate professor in 2017 at Eindhoven University of Technology. In 2020, he was promoted to Full Professor at the University of Amsterdam where he is the Chair of Flow Chemistry. His research interests are synthetic organic chemistry and technology, and especially the delicate synergy between these two fields. His research on flow chemistry was recognized with several awards, including the DECHEMA award (2017), the Hoogewerff Jongerenprijs (2019), the IUPAC-ThalesNano Flow Chemistry Award (2020), the KNCV Gold Medal (2021) and the ACS Sustainable Chemistry & Engineering Lectureship Award 2022. He is the editor in chief of Journal of Flow Chemistry.

Prof. Gianvito Vilé

Prof. Gianvito Vilé is a Tenure-Track Assistant Professor in Chemical Engineering at Politecnico di Milano. He studied Chemical Engineering in Italy and received his PhD from ETH Zurich. Before joining Politecnico di Milano, he was a Lab Head at Idorsia Pharmaceuticals. His current research focuses on the understanding of the structure and reactivity of single-atom catalysts, and on the design of sustainable chemical methodologies for synthesis. He has received numerous awards for his research, including the ETH Zurich Medal, the Dimistris N. Chorafas Award, the Felder Award, and the Alfredo di Braccio prize. In 2022, he was awarded an ERC Starting Grant to develop synthetic methodologies based on single-atom catalysts. He sits on the editorial board of several journals, such as ChemCatChem, ACS ES&T Engineering, and Molecular Catalysis.

Prof. Alina M. Balu

Alina M. Balu (Ph.D 2012 from Universidad de Cordoba, Spain) has extensively published (>100 peer-reviewed publications, h-index 38, >4,000 citations) in the areas of (nano)materials science, heterogeneous (nano)catalysis, flow chemistry, biofuels and green chemical methods in synthetic organic chemistry, filed 2 patent applications and edited 2 books as well as 7 contributions to book chapters. Prof. Balu is also member of the Editorial Board of Molecular Catalysis (Elsevier), Scientific Reports (Springer-Nature), among other journals.

Dr. Andrea Aramini

Andrea Aramini earned his B.D. degree in 1999 from the Faculty of Chemistry of University of Perugia (Italy) where he held his post-bachelor specialization. After his specialization period, Andrea joined Dompé s.p.a and, from 2002 to 2004, was Medicinal Chemistry Researcher in the Chemistry Dept. of Dompé Research Center in L’Aquila. From November 2004 to 2006 he headed the Chemistry Laboratory and from 2006 Chemistry Department of Dompé Research Centre. In April 2018 Andrea was appointed as Head of Research & Early Development - VP at Dompé S.p.A. A dedicated professional with 10+ years of experience in Drug Discovery, Preclinical Development and Innovation, focus on Ophthalmology, Immuno-oncology, Inflammation, Metabolic disorder and CNS. Andrea’s major scientific achievements concern the research in the medicinal chemistry area, specifically targeted to the rational drug design of novel 7TM-GPCR modulators. Andrea and his collaborators have identified a novel approach to the targeted modulation of peptidergic G-protein coupled receptors, the largest super-family of cellular receptors involved in several diseases belonging to a variety of therapeutic areas.

Dr. Farnaz Sotoodeh

Farnaz Sotoodeh has obtained her PhD in Chemical Engineering from the University of British Columbia, Canada. She is specialised in the field of heterogeneous catalysis for hydrogen storage on LOHCs, and has several years of experience in both academia and commercial research. Farnaz is an expert in synthesising high-performance catalysts. At C2CAT, Farnaz leads the implementation of fundamental discoveries into synthesis of novel and tailor-made catalysts.

Dr. Vesna Middelkoop

Vesna Middelkoop has an interdisciplinary background in Materials Science and Physics and a specialist experience in a variety of materials design, reactor engineering and project management roles. She obtained a PhD degree in the field of synchrotron X-Ray characterization of materials synthesis processes from the University of London in 2010, having worked within the Industrial Materials Group of the University College London, Chemistry Department and Birkbeck College, Crystallography Department. Her expertise lies in materials synthesis and development of chemical reactors and their advanced characterization. She has been working in the R&D industry in London before joining VITO, as a project engineer responsible for the strategic planning and management of projects on instrumental set-ups and materials measurements. Her current research focus is the development of novel structured materials for catalytic conversion and adsorption within EU-funded and industrial contract research projects. More specifically, she is a project lead in several HORIZON 2020 and HORIZON EUROPE projects in the areas of materials design for CO2 utilisation and renewable fuels production (CARMOF, KEROGREEN, ZEOCAT-3D, GLAMOUR, ORACLE, HYSTRAM, STORMING) and is the coordinator of CO2Fokus.

Inga Grigaliūnaitė

Inga Grigaliūnaitė (female, MSc degree, Chemical engineering, University of Twente) has been working within FeyeCon group for 11 years within renewable and fats & oil team as project leader. She has been focusing on Sc-CO2 downstream processing of biomaterials and focusing on creating sustainable, green, viable and feasible product and process development.

Prof. Brahim Benyahia

Brahim Benyahia is a Reader of Chemical Engineering and Pharmaceutical Manufacturing at Loughborough University, UK. He is currently investigator and member of several national and international research consortia including the Future Manufacturing Hub for Continuous Manufacturing and Advanced Crystallization (CMAC HUB), the Digital Medicines Manufacturing Research Centre (EPSRC DM2) and SusPharma - Merging Sustainable and Digital Chemical Technologies. He has a well-established expertise in Integrated Continuous Pharmaceutical Manufacturing, Digitalization, Quality-by-Design, as well as Plant-Wide Modelling Optimization and Control. He also played a key role in the development of the first End-to-End Integrated Continuous Pharmaceutical Manufacturing Platform at MIT, USA (a $65 M Novartis-MIT project).